Geneformics Selected By WuXi NextCODE To Reduce Data Footprint Of Massive, Global Genomics Data

SUNNYVALE, Calif.--(BUSINESS WIRE)--Geneformics Data Systems Limited, a leader in Genomics IT Infrastructures that advance the accessibility of transfer, storage and archiving of next generation sequencing data, and WuXi NextCODE, the global contract genomics organization enabling precision medicine around the world, today announced a collaborative effort to integrate Geneformics technology into WuXi NexCODE’s workflows.

“Organizing, mining and sharing genomic big data is at the heart of our CGO model, and we expect Geneformics will help us to significantly reduce our data footprint to the benefit of our customers and to patients globally”

Geneformics leverages proprietary, optimized compression technologies to streamline the storage and sharing of genomics data in the cloud and on-premise. WuXi NextCODE’s database and analytics underpin the world’s leading population-scale precision medicine projects as well as pioneering diagnostics and wellness solutions on four continents. Together the companies intend to improve the efficiency of storing and transferring large-scale genomic data globally and increase the potential benefit of these datasets to patients.

The sequencing of a single whole genome generates more than 100 GB of raw data, making the storage, transfer and archiving of genomic data a huge challenge for the industry. Geneformics’ lossless compression has been demonstrated to reduce raw file size by up to 90 percent; combined with its storage and archiving technology, large genomic datasets can be compiled and queried on-site, remotely, or transferred online - with very significant efficiencies. Integrating Geneformics into the WuXi NextCODE platform thereby makes bigger datasets more accessible for precision medicine research, diagnosis and treatment.

“The combination of Geneformics’ technology and WuXi NextCODE’s workflows will enable a large range of customers to benefit from high-speed data transfer, efficient storage and archiving of genome sequence data,” said Rafael Feitelberg, Geneformics CEO. “As the platform for leading precision medicine efforts in the UK, Ireland, Qatar, Singapore, China and the US, WuXi NextCODE is an ideal technology partner. Together we will enable partners and customers to accelerate the discovery of data insights and reduce infrastructure costs.”

“Organizing, mining and sharing genomic big data is at the heart of our CGO model, and we expect Geneformics will help us to significantly reduce our data footprint to the benefit of our customers and to patients globally,” said Hannes Smarason, COO of WuXi NextCODE. “Geneformics does this through fast, lossless data compression and decompression, so customers can seamlessly access all their data, wherever it is sequenced or stored. Used in tandem with our sequencing, database and analytics, that gives CGO customers unrivalled power to solve rare disease cases, drive breakthrough discoveries, deliver carrier screening, tailor cancer treatment and support wellness.”

For more information on Geneformics or to schedule a demo, visit www.geneformics.com.

About Geneformics

Geneformics is a technology leader in genomic data management and compression. Based on proprietary technology co-developed by the company’s bioinformaticians, computer engineers and the Weizmann Institute, Geneformics makes genomic data accessible by mitigating the complexity of massive data sets. The company’s solutions are implemented globally to optimize data transfer, storage and archiving, enabling the positive impact of precision. With offices in Silicon Valley and Israel, Geneformics is backed by international venture capital.

About WuXi NextCODE

WuXi NextCODE is a fully integrated global contract genomics organization. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we offer comprehensive services that enable population, precision medicine, diagnostics and wellness initiatives and enterprises to use the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a subsidiary of WuXi AppTec. Visit us on the web at wuxinextcode.com.